Department of Obstetrics and Gynecology, The College of Medicine, The Ohio State University, Columbus, Ohio, USA.
Department of Sociology, University of Cincinnati, Cincinnati, Ohio, USA.
Telemed J E Health. 2023 Mar;29(3):414-424. doi: 10.1089/tmj.2022.0101. Epub 2022 Jul 19.
The convenience and privacy provided by telemedicine medication abortion may make this service preferable to patients who mistrust their abortion provider. We assessed associations between mistrust in the abortion provider and preferences for telemedicine abortion. From April 2020 to April 2021, we surveyed patients seeking abortion in Ohio, West Virginia, and Kentucky. Using unconditional logistic regression models, we examined unadjusted and adjusted associations between mistrust in the abortion provider and preferences for telemedicine abortion among all participants, and among only participants undergoing medication abortion. Of 1,218 patients who met inclusion criteria, 546 used medication abortion services. Just more than half (56%) of all participants and many (64%) of medication abortion participants preferred telemedicine services. Only 6% of medication abortion participants received telemedicine medication dispensing services. Only 1.4% of all participants and 1% of medication abortion participants mistrusted the abortion provider. Participants who mistrusted the abortion provider were somewhat more likely to prefer telemedicine abortion (unadjusted odds ratio [OR]: 2.5, 95% CI: 0.8-7.9; adjusted OR: 2.9, 95% CI: 0.9-9), and medication abortion participants who mistrusted the abortion provider were also somewhat more likely to prefer telemedicine abortion (unadjusted OR: 3.5, 95% CI: 0.4-28.9; adjusted OR: 5.0, 95% CI: 0.6-43), although these associations were not statistically significant. In three abortion-restrictive states, most patients expressed preferences for telemedicine abortion, but few accessed them. Provider mistrust was rare, but those experiencing mistrust trended toward preferring telemedicine services. Telemedicine may improve access to abortion services for patients experiencing medical mistrust.
远程医疗药物流产提供的便利性和隐私性可能使这项服务对不信任堕胎提供者的患者更具吸引力。我们评估了对堕胎提供者的不信任与对远程医疗堕胎的偏好之间的关联。
从 2020 年 4 月至 2021 年 4 月,我们调查了在俄亥俄州、西弗吉尼亚州和肯塔基州寻求堕胎的患者。使用无条件逻辑回归模型,我们检查了所有参与者以及仅接受药物流产的参与者中,对堕胎提供者的不信任与对远程医疗流产的偏好之间的未经调整和调整关联。
在符合纳入标准的 1218 名患者中,有 546 名使用药物流产服务。超过一半(56%)的所有参与者和许多(64%)药物流产参与者更喜欢远程医疗服务。只有 6%的药物流产参与者接受远程医疗药物配药服务。只有 1.4%的所有参与者和 1%的药物流产参与者不信任堕胎提供者。不信任堕胎提供者的参与者更倾向于选择远程医疗堕胎(未经调整的优势比[OR]:2.5,95%置信区间[CI]:0.8-7.9;调整后的 OR:2.9,95% CI:0.9-9),而且不信任堕胎提供者的药物流产参与者也更倾向于选择远程医疗堕胎(未经调整的 OR:3.5,95% CI:0.4-28.9;调整后的 OR:5.0,95% CI:0.6-43),尽管这些关联没有统计学意义。在三个堕胎限制严格的州,大多数患者表示对远程医疗堕胎的偏好,但很少有人使用。提供者的不信任虽然很少见,但经历过不信任的人更倾向于选择远程医疗服务。远程医疗可能会改善对经历医疗不信任的患者的堕胎服务获取。